X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
canakinumab (93) 93
anakinra (65) 65
index medicus (61) 61
humans (48) 48
rheumatology (42) 42
etanercept (28) 28
tocilizumab (25) 25
juvenile idiopathic arthritis (24) 24
male (22) 22
medicine & public health (22) 22
efficacy (21) 21
female (20) 20
arthritis (19) 19
rheumatoid-arthritis (19) 19
familial mediterranean fever (18) 18
double-blind (17) 17
interleukin-1 (17) 17
interleukin-1 receptor antagonist (17) 17
abatacept (16) 16
inflammation (16) 16
treatment outcome (16) 16
child (15) 15
cytokines (15) 15
infliximab (15) 15
rilonacept (15) 15
adolescent (14) 14
adalimumab (13) 13
antibodies, monoclonal - therapeutic use (13) 13
care and treatment (13) 13
placebo-controlled trial (13) 13
antirheumatic agents - therapeutic use (12) 12
child, preschool (12) 12
children (12) 12
macrophage activation syndrome (12) 12
interleukin 1 receptor antagonist protein - therapeutic use (11) 11
interleukins (11) 11
internal medicine (11) 11
mutation (11) 11
open-label (11) 11
patient (11) 11
adult (10) 10
pathogenesis (10) 10
pediatrics (10) 10
rituximab (10) 10
abridged index medicus (9) 9
animals (9) 9
arthritis, juvenile - drug therapy (9) 9
autoinflammatory diseases (9) 9
immunology (9) 9
interleukin-1beta - antagonists & inhibitors (9) 9
pharmacology & pharmacy (9) 9
review (9) 9
treatment (9) 9
young adult (9) 9
antibodies, monoclonal - adverse effects (8) 8
antirheumatic agents - adverse effects (8) 8
biologics (8) 8
colchicine (8) 8
middle aged (8) 8
patients (8) 8
receptor antagonist anakinra (8) 8
systemic juvenile idiopathic arthritis (8) 8
uveitis (8) 8
amyloidosis (7) 7
analysis (7) 7
autoinflammatory (7) 7
biological products - therapeutic use (7) 7
familial mediterranean fever - drug therapy (7) 7
fever (7) 7
methotrexate (7) 7
muckle-wells-syndrome (7) 7
safety (7) 7
therapy (7) 7
tumor necrosis factor-tnf (7) 7
aa amyloidosis (6) 6
colchicine - therapeutic use (6) 6
disease (6) 6
drug therapy (6) 6
health aspects (6) 6
inflammatory diseases (6) 6
interleukin 1 (6) 6
interleukin 1 receptor antagonist protein - adverse effects (6) 6
medicine, general & internal (6) 6
of-the-literature (6) 6
anakinra treatment (5) 5
anti-inflammatory agents - therapeutic use (5) 5
autoinflammatory disease (5) 5
caps (5) 5
cold autoinflammatory syndrome (5) 5
diagnosis (5) 5
drugs (5) 5
familial mediterranean fever - genetics (5) 5
genetic aspects (5) 5
hereditary autoinflammatory diseases - diagnosis (5) 5
il-1 (5) 5
inflammasome (5) 5
interleukin-1beta - immunology (5) 5
interleukin-1β (5) 5
long-term safety (5) 5
monoclonal antibodies (5) 5
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Arthritis & Rheumatology, ISSN 2326-5191, 10/2015, Volume 67, Issue 10, pp. 2759 - 2770
Journal Article
Arthritis research & therapy, ISSN 1478-6354, 12/2018, Volume 20, Issue 1, pp. 285 - 11
Journal Article
Rheumatology (United Kingdom), ISSN 1462-0324, 01/2014, Volume 53, Issue 1, pp. 32 - 38
Journal Article
Seminars in Arthritis and Rheumatism, ISSN 0049-0172, 02/2019, Volume 48, Issue 4, pp. 618 - 625
The SAPHO syndrome is a relatively rare clinical entity characterized by a wide range of dermatological and musculoskeletal manifestations. Biologics have been... 
Golimumab | IL-1 | Certolizumab | Anti-TNF | Ustekinumab | Rituximab | Secukinumab | Canakinumab | IL-23 | IL-6 | tocilizumab | Treatment | Infliximab | Etanercept | Abatacept | Biologics | IL-17 | SAPHO | Adalimumab | Anakinra | HYPEROSTOSIS-OSTEITIS SAPHO | TNF-ALPHA THERAPY | ANKYLOSING-SPONDYLITIS | OSTEOMYELITIS | PUSTULOSIS | T-CELLS | RHEUMATOLOGY | PATIENT | Monoclonal antibodies | Antiarthritic agents | Medical colleges | Skin diseases | Skin
Journal Article
The American Journal of the Medical Sciences, ISSN 0002-9629, 2012, Volume 346, Issue 2, pp. 137 - 141
Abstract Objective Colchicine is the mainstay treatment for Familial Mediterranean Fever (FMF). However 5% to 10% of the patients with FMF are unresponsive or... 
Internal Medicine | Infliximab | Etanercept | Adalimumab | Canakinumab | Anakinra | Familial Mediterranean Fever | RHEUMATOID-ARTHRITIS | ALPHA THERAPY | THERAPEUTIC APPROACH | TNF | AA AMYLOIDOSIS | RESISTANT | MEDICINE, GENERAL & INTERNAL | COLCHICINE | PATIENT | Humans | Familial Mediterranean Fever - therapy | Biological Products - therapeutic use
Journal Article
Current Rheumatology Reports, ISSN 1523-3774, 11/2015, Volume 17, Issue 11, pp. 1 - 10
During the past 15 years, biologics for juvenile idiopathic arthritis (JIA) therapy has led to new options. However, despite the high effectiveness and safety... 
Medicine & Public Health | Abatacept | Etanercept | Infliximab | Tocilizumab | Rheumatology | Infections | Safety | Adalimumab | Canakinumab | Pediatric | Juvenile idiopathic arthritis | EFFICACY | WITHDRAWAL TRIAL | OPEN-LABEL | RHEUMATOLOGY | INFLIXIMAB PLUS METHOTREXATE | LONG-TERM SAFETY | HERPES-ZOSTER | DOUBLE-BLIND | JIA REGISTRY | Pediatrics | Bacterial infections | Methotrexate | T cells | Health aspects
Journal Article